SUPRAX

Product NDC: 27437-208
11-digit product format: 274370208
Labeler code: 27437
Product ID: 27437-208_0e44b51b-cba9-4dc5-8ee1-2d151ad24def
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cefixime
Dosage form: CAPSULE
Route: ORAL
Labeler: Lupin Pharmaceuticals, Inc.
Application: NDA203195
Marketing category: NDA
Marketing start: 2013-03-15
Marketing end: 0000-00-00
Substance: CEFIXIME
Active strength: 400 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	27437-208		D	Discontinued by firm	2026-08-17
excluded package	package	27437-208	27437-208-02	D	Discontinued by firm	2026-08-17
excluded package	package	27437-208	27437-208-08	D	Discontinued by firm	2026-08-17
excluded package	package	27437-208	27437-208-11	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	27437-208-11	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	27437-208-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	27437-208-08	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	27437-208-11	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	27437-208-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	27437-208-08	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	27437-208-11	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	27437-208-08	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	27437-208-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	27437-208-11	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	27437-208-08	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	27437-208-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	27437-208-11	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	27437-208-08	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	27437-208-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	27437-208-11	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	27437-208-08	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	27437-208-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	27437-208-11	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	27437-208-08	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	27437-208-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	27437-208-11	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	27437-208-08	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	27437-208-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	27437-208-11	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	27437-208-08	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	27437-208-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	27437-208-11	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	27437-208-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	27437-208-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	27437-208-11	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	27437-208-08	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	27437-208-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	27437-208-11	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	27437-208-08	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	27437-208-02	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N203195-001	SUPRAX	CEFIXIME	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N203195-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2012-06-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N203195-001	SUPRAX	400MG	CAPSULE / ORAL		RLD	2012-06-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N203195-001	SUPRAX	400MG	CAPSULE / ORAL		RLD	2012-06-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N203195-001	SUPRAX	400MG	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2012-06-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL		RLD	2012-06-01	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N203195-001	SUPRAX	400MG	CAPSULE / ORAL		RLD	2012-06-01	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N203195-001	SUPRAX	400MG	CAPSULE / ORAL		RLD	2012-06-01	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N203195-001	SUPRAX	400MG	CAPSULE / ORAL		RLD	2012-06-01	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N203195-001	SUPRAX	400MG	CAPSULE / ORAL		RLD	2012-06-01	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N203195-001	SUPRAX	400MG	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N203195-001	SUPRAX	400MG	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N203195-001	SUPRAX	400MG	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N203195-001	SUPRAX	400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD, RS	2012-06-01	`e64feba35796…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N203195-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N203195-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203195-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N203195-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203195-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203195-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203195-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203195-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203195-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203195-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N203195-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203195-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203195-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203195-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N203195-001	AB	1	`8072bd15b7f6…`
2019-12-13 00:20 UTC	2019-12	N203195-001	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N203195-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N203195-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N203195-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N203195-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N203195-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N203195-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N203195-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N203195-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N203195-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N203195-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N203195-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N203195-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N203195-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N203195-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N203195-001	AB	1	`e64feba35796…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N203195-001	AB	1	`a50c72e98297…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
3b2162c7-9766-84dc-4509-6d61a89e78a5	Product name	5	20210729
7953affb-a49b-11df-6839-b5f62ce45d92	Product name	6	20210729

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
27437-208-08	EA - Each	27437-208	963e442f-3626-4646-9b50-8baf11b1cb57	1	2014-05-02
27437-208-11	EA - Each	27437-208	3613fc97-ae76-42f6-af40-9df98c65c0cf	1	2013-06-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFIXIME	ACTIVE INGREDIENT	97I1C92E55	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
CEFIXIME ANHYDROUS	ACTIVE MOIETY	XZ7BG04GJX	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
GELATIN	INACTIVE INGREDIENT	2G86QN327L	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
SHELLAC	INACTIVE INGREDIENT	46N107B71O	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
STRAWBERRY	INACTIVE INGREDIENT	4J2TY8Y81V	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
SUCROSE	INACTIVE INGREDIENT	C151H8M554	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	SUPRAX (CEFIXIME) TABLET SUPRAX (CEFIXIME) CAPSULE SUPRAX (CEFIXIME) TABLET, CHEWABLE SUPRAX (CEFIXIME) POWDER, FOR SUSPENSION [LUPIN PHARMA]	5
CEFIXIME	ACTIVE INGREDIENT	97I1C92E55	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
CEFIXIME ANHYDROUS	ACTIVE MOIETY	XZ7BG04GJX	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
GELATIN	INACTIVE INGREDIENT	2G86QN327L	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED	INACTIVE INGREDIENT	2165RE0K14	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
POTASSIUM HYDROXIDE	INACTIVE INGREDIENT	WZH3C48M4T	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
SHELLAC	INACTIVE INGREDIENT	46N107B71O	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SUPRAX (CEFIXIME) CAPSULE [PD-RX PHARMACEUTICALS, INC.]	4

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CEFIXIME	CEFIXIME	REMEDYREPACK INC.	3194433c-c04e-442b-9668-fbeb0a15bac7	2026-08-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 203195 application number: NDA203195
CEFIXIME	CEFIXIME	Lupin Pharmaceuticals, Inc.	6d68dbd9-7d75-4ff1-91db-79ff8ae879ec	2025-10-14	Warnings, Adverse reactions	Exact identifier application applno (NDA): 203195 application number: NDA203195

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
97I1C92E55	CEFIXIME	125110-14-7	CEFIXIME

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
409823	cefixime 400 MG Oral Capsule	PSN	655a59ba-08e9-51d4-e053-2991aa0aef34	2
1372999	Suprax 400 MG Oral Capsule	PSN	655a59ba-08e9-51d4-e053-2991aa0aef34	2
1372999	cefixime 400 MG Oral Capsule [Suprax]	SBD	655a59ba-08e9-51d4-e053-2991aa0aef34	2
409823	cefixime 400 MG Oral Capsule	SCD	655a59ba-08e9-51d4-e053-2991aa0aef34	2
1372999	Suprax 400 MG Oral Capsule	SY	655a59ba-08e9-51d4-e053-2991aa0aef34	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
27437-208-02	27437020802	1 BLISTER PACK in 1 CARTON (27437-208-02) > 1 CAPSULE in 1 BLISTER PACK	1 blister pack	2013-03-15	0000-00-00	No	No	Current
27437-208-08	27437020808	50 CAPSULE in 1 BOTTLE (27437-208-08)	50 capsule	2013-03-15	0000-00-00	No	No	Current
27437-208-11	27437020811	1 BLISTER PACK in 1 CARTON (27437-208-11) > 10 CAPSULE in 1 BLISTER PACK	1 blister pack	2013-03-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
SUPRAX	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2023-12-15	HUMAN PRESCRIPTION DRUG LABEL	14
SUPRAX	PharmPak, Inc.	2022-10-09	HUMAN PRESCRIPTION DRUG LABEL	2
SUPRAX	PD-Rx Pharmaceuticals, Inc.	2020-02-18	HUMAN PRESCRIPTION DRUG LABEL	16
SUPRAX	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2019-12-27	HUMAN PRESCRIPTION DRUG LABEL	2
SUPRAX	REMEDYREPACK INC.	2019-04-09	HUMAN PRESCRIPTION DRUG LABEL	1
SUPRAX	REMEDYREPACK INC.	2018-12-17	HUMAN PRESCRIPTION DRUG LABEL	4